Bio-Rad Laboratories Inc (BIO) Q3 2024 Earnings Call Highlights: Strong Clinical...

Published on 31 Oct 2024 on GuruFocus.com · via Yahoo Finance

Net Sales: $650 million, a 2.8% increase from Q3 2023. Life Science Group Sales: $261 million,...

Read the rest of the article

Start tracking your investments with Statfolio

The company's net income saw a significant surge to $653 million, largely due to a substantial ga...

Investing.com 31 Oct 2024

Net Sales: $650 million, a 2.8% increase from Q3 2023. Life Science Group Sales: $261 million,...

GuruFocus.com · via Yahoo Finance 31 Oct 2024

We recently compiled a list of the 10 Best Organ Transplant and Diagnosis Stocks To Buy Now. In t...

Insider Monkey · via Yahoo Finance 19 Aug 2024

The first-quarter results for Bio-Rad Laboratories, Inc. (NYSE:BIO) were released last week, maki...

Simply Wall St. via Yahoo Finance 10 May 2024

Bio-Rad Laboratories, Inc. BIO posted first-quarter 2024 adjusted earnings per share (EPS) of $2....

Zacks via Yahoo Finance 8 May 2024

Bio-Rad Laboratories, Inc. (NYSE:BIO) Q1 2024 Earnings Call Transcript May 7, 2024 Bio-Rad Labora...

Insider Monkey via Yahoo Finance 8 May 2024

Revenue: Reported $610.8 million, a decrease of 9.8% year-over-year, falling short of estimates o...

GuruFocus.com via Yahoo Finance 7 May 2024

(NASDAQ: ONCY) (TSX: ONC), Celcuity Inc. (NASDAQ: CELC), Olema Pharmaceuticals, Inc. (NASDAQ: OLM...

WTNH-TV New Haven 3 May 2024

The S&P 500 opened today at 5,028.85. Within 30 minutes of trading, the benchmark index rose by...

USA Today 23 Apr 2024

Here are three stocks added to the Zacks Rank #5 (Strong Sell) List today: ATN International, Inc...

Zacks via Yahoo Finance 19 Apr 2024